Condensed Consolidated Statements of Operations (unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Operating expenses:
Research and development	$ 27,828	$ 15,003
General and administrative	18,027	12,745
Total operating expenses	45,855	27,748
Loss from operations	(45,855)	(27,748)
Investment income, net	3,466	2
Other expense, net	(4)	(1)
Net loss attributable to common stockholders	$ (42,393)	$ (27,747)
Net loss per share, Basic	$ (0.59)	$ (0.48)
Net loss per share, Diluted	$ (0.59)	$ (0.48)
Weighted-average number of common shares used in computing net loss per share, basic	71,972,888	58,382,444
Weighted-average number of common shares used in computing net loss per share, Diluted	71,972,888	58,382,444